DateTitleLink
2020Development of novel CAR T engager proteins for cell therapies that target metastatic and primary CNS malignancies
– SITC 2020
VIEW PDF
2020A Novel Platform For Cell Therapeutics
– OCTS July 2020
VIEW SLIDES
2019Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
– Mol Pharm. 2019
VIEW ARTICLE
2019Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design
– Biochemistry. 2019
VIEW ARTICLE
2019A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo
– ASH 2019 #252
VIEW PDF
2018Hijacking CAR19 T cells to target diverse hematologic and solid tumors
– SITC 2018 #267
VIEW PDF
2018CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types
– AACR 2018 #2569
VIEW PDF
2017CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies
– ASH 2017 #4457
VIEW PDF
2017CAR T cells specific for CD19 can be redirected to kill CD19 negative tumors
– AACR 2017 #3768
VIEW PDF